Browsing by Author O'Brien, Richard C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2016Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyGeorge, Jacob; Jenkins, Alicia; Keech, Anthony (Tony); Sullivan, David; Twigg, Stephen; Veillard, Anne-Sophie; Williams, Kathryn; Duffield, A; Ehnholm, Christian P; O'Brien, Richard C; Young, Simon; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: MedicineLow alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, Diabetic Medicine, vol.33, 3, 2016,pp 356-364
2016Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyBuizen, L; Donoghoe, Mark William; Gebski, Val; George, Jacob; Januszewski, Andrzej Szczesny; Jenkins, Alicia; Keech, Anthony (Tony); Sullivan, David; Twigg, Stephen; Williams, Kathryn; Ehnholm, Christian P; Manning, Patrick; Nicholson, Geoff; O'Brien, Richard C; Tan, Yong Mong; Young, Simon; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: MedicineOpposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, Metabolism: Clinical and Experimental, vol.65, 5, 2016,pp 783-793